Although BRCA2 mutations were not detected in the GEL cohort, tumours exhibiting recurrent deletions spanning BRCA2 displayed a significantly higher prevalence of signature S2 rearrangements (p = 0.001528, Wilcoxon rank sum test). This evidence concerns the gene BRCA2 and neoplasm.